Skip to content

A randomized placebo-controlled study: The effect of Siang Pure Oil in patients with functional dyspepsia

A randomized placebo-controlled study: The effect of Siang Pure Oil in patients with functional dyspepsia

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230418004
Enrollment
150
Registered
2023-04-18
Start date
2023-05-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia Dyspepsia

Interventions

Siang pure oil formula 1 5 drops apply to skin at upper abdominal region after meal 3 times a day for 28 days,Siang pure oil formula 2 5 drops apply to skin at upper abdominal region after meal 3 time
Siang pure oil 1,Siang Pure Oil 2,Placebo

Sponsors

Bertram (1958) co. ltd
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. age 18-80 years 2. diagnosed with functional dyspepsia based on ROME IV criteria with mild to very Severe Symptoms evaluated by Gastrointestinal Overall Symptom (GOS) Scale within 28 days prior to enrollment 3. symptom of abdominal bloating with specific symptom GOS Scale of at least 2 points within 28 days prior to enrollment 4. history of normal upper endoscopy within 5 years before enrollment

Exclusion criteria

Exclusion criteria: 1. adjustment of continuous dyspepsia medications within 1 month prior to enrollment 2. presence of H.pylori infection or eradication less than 3 months prior to enrollment 3. pregnant or breast feeding

Design outcomes

Primary

MeasureTime frame
Percentage of patients with self-reported satisfaction at 28 days 28 days of treatment patients with over 50% satisfaction in 28 days,GOS improvement (GOS28) 28 days of treatment GOS (total, specific symptoms)

Secondary

MeasureTime frame
Percentage of patients with self-reported satisfaction at 2 days 2 days of treatment patients with over 50% satisfaction in 2 days,Percentage of patients with self-reported satisfaction at 14 days 14 days of treatment patients with over 50% satisfaction in 14 days,GOS improvement (GOS2) 2 days of treatment GOS (total, specific symptoms),GOS improvement (GOS14) 14 days of treatment GOS (total, specific symptoms),Quality of life 28 days of treatment SF-NDI,Adverse effects 28 days of treatment Adverse effects reported by patients

Countries

Thailand

Contacts

Public ContactKanokwan Pinyopornpanish

Chiang Mai University

kpinyopornpanish@gmail.com0896338078

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026